Hamburg-based atmio, a pioneering climate tech startup, has secured €5.1 million in a seed round aimed at transforming how natural gas companies monitor and mitigate methane emissions. Led by Notion Capital with participation from SquareOne, HCVC, Robin Capital, and notable angel investors including Bernhard Mohr and David Rowan’s VOYAGERS Climate-Tech Fund, this funding marks a…
In a significant stride towards combating climate change, Sirona Technologies has successfully raised €6 million in a Seed round to propel its innovative Direct Air Capture (DAC) technology. This funding, co-led by LocalGlobe and XAnge, underscores growing investor confidence in Sirona’s mission to revolutionize carbon removal from the atmosphere. Founded in 2023 and headquartered in…
In a bold move towards sustainable pet care, Tuggs, the innovative startup specializing in insect-based dog food, has successfully raised £1.1 million in funding from a range of institutional investors and angel backers. The fresh dog food brand combines insect proteins with meats, fish, and vegetables to create a product line that prioritizes both canine…
In a significant stride towards advancing treatments for severe bone and connective tissue disorders, āshibio emerges from stealth mode with a remarkable $40 million infusion from its Seed and Series A financing rounds. Spearheaded by MPM BioImpact and bolstered by investments from Agent Capital, YK Bioventures, and Mirae Asset Venture Investment, this funding positions āshibio…
Viz.ai, a trailblazer in AI-driven disease detection and intelligent care coordination, has announced a groundbreaking partnership with the Addario Lung Cancer Medical Institute (ALCMI), a leading international consortium of 25 top lung cancer research institutions. This new collaboration aims to revolutionize early lung cancer detection and enhance patient outcomes through advanced clinical workflows and precision…
Cambridge-based Wave Photonics has achieved a significant milestone in its journey to revolutionize deeptech with a £4.5M (€5.32M) seed funding round. Spearheaded by UK Innovation & Science Seed Fund and Cambridge Enterprise Ventures, this funding will drive the development of cutting-edge on-chip photonics designs aimed at quantum technologies, sensors, and data centers. Dr. Christine Martin,…
The Amherst Group (“Amherst”), a prominent player in residential real estate investments, has appointed Paul Nicholson as its Deputy Chief Investment Officer. Nicholson returns to Amherst from Santander US Capital Markets, bringing extensive experience in mortgage-backed securities (MBS) and risk management. In his new role, Nicholson will collaborate closely with Chairman and CEO Sean Dobson…
Alosant, a trailblazer in customer experience technology for master-planned communities, proudly announces the completion of its Series A funding round, spearheaded by Greg Avis, co-founder and former Managing Director of Summit Partners. This pivotal development, combined with strategic leadership appointments, positions Alosant for significant growth and innovation in the proptech sector. Greg Avis, now Managing…
Thyme Care, a trailblazer in value-based cancer care solutions, has successfully closed a $95 million Series C funding round, marking a significant milestone in its mission to revolutionize cancer care accessibility and affordability. This financing, comprising $55 million in equity from new investor Concord Health Partners and existing supporters like CVS Health® Ventures, Town Hall…
Jade Biosciences, a biotechnology innovator focused on autoimmune diseases, has announced the successful closing of an $80 million financing round. Led by Fairmount and Venrock Healthcare Capital Partners, with additional contributions from Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, and Braidwell LP, this investment will drive the development of Jade’s cutting-edge therapies…
